2-178706970-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001267550.2(TTN):​c.29042-16G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.043 in 1,588,458 control chromosomes in the GnomAD database, including 3,160 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.063 ( 498 hom., cov: 33)
Exomes 𝑓: 0.041 ( 2662 hom. )

Consequence

TTN
NM_001267550.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.0280

Publications

3 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 2-178706970-C-T is Benign according to our data. Variant chr2-178706970-C-T is described in ClinVar as Benign. ClinVar VariationId is 137774.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.151 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001267550.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TTN
NM_001267550.2
MANE Select
c.29042-16G>A
intron
N/ANP_001254479.2
TTN
NM_001256850.1
c.28091-16G>A
intron
N/ANP_001243779.1
TTN
NM_133378.4
c.25310-16G>A
intron
N/ANP_596869.4

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TTN
ENST00000589042.5
TSL:5 MANE Select
c.29042-16G>A
intron
N/AENSP00000467141.1
TTN
ENST00000446966.2
TSL:1
c.29042-16G>A
intron
N/AENSP00000408004.2
TTN
ENST00000436599.2
TSL:1
c.28766-16G>A
intron
N/AENSP00000405517.2

Frequencies

GnomAD3 genomes
AF:
0.0625
AC:
9507
AN:
152098
Hom.:
480
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0946
Gnomad AMI
AF:
0.0428
Gnomad AMR
AF:
0.141
Gnomad ASJ
AF:
0.0207
Gnomad EAS
AF:
0.0260
Gnomad SAS
AF:
0.161
Gnomad FIN
AF:
0.0575
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0249
Gnomad OTH
AF:
0.0484
GnomAD2 exomes
AF:
0.0748
AC:
15874
AN:
212282
AF XY:
0.0737
show subpopulations
Gnomad AFR exome
AF:
0.0966
Gnomad AMR exome
AF:
0.187
Gnomad ASJ exome
AF:
0.0248
Gnomad EAS exome
AF:
0.0288
Gnomad FIN exome
AF:
0.0565
Gnomad NFE exome
AF:
0.0260
Gnomad OTH exome
AF:
0.0554
GnomAD4 exome
AF:
0.0409
AC:
58715
AN:
1436242
Hom.:
2662
Cov.:
30
AF XY:
0.0433
AC XY:
30855
AN XY:
712656
show subpopulations
African (AFR)
AF:
0.0955
AC:
3143
AN:
32924
American (AMR)
AF:
0.182
AC:
7439
AN:
40842
Ashkenazi Jewish (ASJ)
AF:
0.0231
AC:
590
AN:
25580
East Asian (EAS)
AF:
0.0133
AC:
519
AN:
39150
South Asian (SAS)
AF:
0.159
AC:
13102
AN:
82476
European-Finnish (FIN)
AF:
0.0578
AC:
2999
AN:
51900
Middle Eastern (MID)
AF:
0.0360
AC:
206
AN:
5720
European-Non Finnish (NFE)
AF:
0.0254
AC:
27914
AN:
1098188
Other (OTH)
AF:
0.0471
AC:
2803
AN:
59462
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2653
5306
7958
10611
13264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1292
2584
3876
5168
6460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0628
AC:
9561
AN:
152216
Hom.:
498
Cov.:
33
AF XY:
0.0673
AC XY:
5006
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0955
AC:
3966
AN:
41522
American (AMR)
AF:
0.141
AC:
2162
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0207
AC:
72
AN:
3472
East Asian (EAS)
AF:
0.0263
AC:
136
AN:
5174
South Asian (SAS)
AF:
0.160
AC:
774
AN:
4824
European-Finnish (FIN)
AF:
0.0575
AC:
609
AN:
10600
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0249
AC:
1691
AN:
68016
Other (OTH)
AF:
0.0479
AC:
101
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
434
868
1303
1737
2171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0406
Hom.:
83
Bravo
AF:
0.0663
Asia WGS
AF:
0.114
AC:
396
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Mar 04, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 08, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 16, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Autosomal recessive limb-girdle muscular dystrophy type 2J Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Early-onset myopathy with fatal cardiomyopathy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Tibial muscular dystrophy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Myopathy, myofibrillar, 9, with early respiratory failure Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.6
DANN
Benign
0.38
PhyloP100
0.028
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10203085; hg19: chr2-179571697; API